Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25945647 | 0.90 | MAP4K1 (0.59) | MAP4K1MAPK14 | |
| SCHEMBL25945213 | 0.84 | MAP4K1 (0.56) | MAP4K1MAPK14 | |
| SCHEMBL25945495 | 0.82 | MAP4K1 (0.63) | MAP4K1 | |
| SCHEMBL21684927 | 0.81 | MAP4K1 (0.63) | MAP4K1 | |
| SCHEMBL21684284 | 0.81 | MAP4K1 (0.76) | MAP4K1 | |
| SCHEMBL25945458 | 0.80 | MAP4K1 (0.63) | MAP4K1 | |
| SCHEMBL25945558 | 0.80 | MAP4K1 (0.75) | MAP4K1 | |
| SCHEMBL25945082 | 0.80 | MAP4K1 (0.51) | MAP4K1MAPK14 | |
| SCHEMBL21684195 | 0.79 | MAP4K1 (0.74) | MAP4K1 | |
| SCHEMBL21684199 | 0.79 | MAP4K1 (0.74) | MAP4K1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219460-A1 | TRANSGLUTAMINASE 2 (TG2) INHIBITORS | Sitari Pharma, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |